VEGFA and neoplasm: A study investigating the role of PAI-1 in a murine xenograft A549 cell tumour model found significantly increased thrombi and shortened occlusion times when treated with an anti-VEGF drug, bevacizumab, which also increased PAI-1 levels in the tumour and plasma [92].